Thioguanine versus mercaptopurine in ALL97: thiopurine metabolism and treatment outcome

Ähnliche Einträge

• The clinical pharmacology of thioguanine vs. mercaptopurine in ALL97, a randomized trial for the treatment of childhood lymphoblastic leukaemia
  von: Lennard, L, et al.
  Veröffentlicht: (2008)
• Thioguanine compared with mercaptopurine in childhood lymphoblastic leukaemia: Results of the United Kingdom medical research council randomised trial ALL97.
  von: Lennard, L, et al.
  Veröffentlicht: (2005)
• MRC ALL97/99 - A randomized comparison of dexamethasone versus prednisolone and thioguanine versus mercaptopurine in the treatment of childhood acute lymphoblastic leukemia.
  von: Mitchell, C, et al.
  Veröffentlicht: (2002)
• Toxicity and efficacy of 6-thioguanine versus 6-mercaptopurine in childhood lymphoblastic leukaemia: a randomised trial.
  von: Vora, A, et al.
  Veröffentlicht: (2006)
• The thiopurine methyltransferase TPMT *1/*3A genotype is associated with a better treatment outcome in the UK ALL97 trial for childhood acute lymphoblastic leukaemia; TPMT heterozygosity is not associated with secondary cancers
  von: Lennard, L, et al.
  Veröffentlicht: (2010)